Browsing by Author Weeke, Peter

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2009Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trialCaterson, Ian; Andersson, Charlotte; Brendorp, Bente; Coutinho, Walmir; Finer, Nick; Fosbol, Emil Loldrup; Kober, Lars; Sharma, Arya; Van Gaal, L; Weeke, Peter; Boden InstituteAcute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial, Metabolism: clinical and experimental, vol.58, 8, 2009,pp 1109-1115
2009Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trialCaterson, Ian; Anderson, Charlotte; Brendorp, Bente; Finer, Nick; Fosbøl, Emil; James, Philip; Køber, Lars; Rode, Richard; Sharma, Arya; Torp-Pedersen, Christian; Weeke, Peter; School of Molecular BioscienceDifferential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial, Nutrition & Metabolism, vol.6, 42,pp 9-N/A
2012Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetesCaterson, Ian; Andersson, Charlotte; Couthino, W.; Finer, Nick; James, W; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, L; Weeke, Peter; Boden InstituteRelationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 9, 2012,pp 2348-2355
2010The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodCaterson, Ian; Andersson, Charlotte; Brendorp, Bente; Finer, Nick; Fosbol, Emil Loldrup; James, Philip; Kober, Lars; Rode, Richard; Sharma, Arya; Torp-Pedersen, Christian; Weeke, Peter; School of Molecular BioscienceThe weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period, BMC Endocrine Disorders, vol.10, 3,pp 1-9